Validation of Measurement Scales in Ocular Graft-versus-Host Disease
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 119 (3) , 487-493
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- National Cancer Institute
- Banyu Life Science Foundation International
This publication has 34 references indexed in Scilit:
- A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-Host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable ChangeTransplantation and Cellular Therapy, 2011
- Rationale and Design of the Chronic GVHD Cohort Study: Improving Outcomes Assessment in Chronic GVHDTransplantation and Cellular Therapy, 2011
- Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumBlood, 2011
- Efficacy in Patients with Dry Eye After Treatment with a New Lubricant Eye Drop FormulationJournal of Ocular Pharmacology and Therapeutics, 2010
- Impact of dry eye disease and treatment on quality of lifeCurrent Opinion in Ophthalmology, 2010
- Methods to Explain the Clinical Significance of Health Status MeasuresMayo Clinic Proceedings, 2002
- Recovery After Stem-Cell Transplantation for Hematologic DiseasesJournal of Clinical Oncology, 2001
- Assessing symptom distress in cancer patientsCancer, 2000
- Recommendations on health-related quality of life research to support labeling and promotional claims in the United StatesQuality of Life Research, 2000
- Reliability and Validity of the Ocular Surface Disease IndexArchives of Ophthalmology (1950), 2000